These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23868481)

  • 1. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.
    Tangka FK; Subramanian S; Beebe MC; Hoover S; Royalty J; Seeff LC
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2863-9. PubMed ID: 23868481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program.
    Subramanian S; Tangka FK; Hoover S; Beebe MC; DeGroff A; Royalty J; Seeff LC
    Cancer; 2013 Aug; 119 Suppl 15(Suppl 15):2855-62. PubMed ID: 23868480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
    Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.
    Subramanian S; Tangka FKL; Hoover S; Royalty J; DeGroff A; Joseph D
    Eval Program Plann; 2017 Jun; 62():73-80. PubMed ID: 28190597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs.
    Subramanian S; Tangka FK; Hoover S; Degroff A; Royalty J; Seeff LC
    Eval Program Plann; 2011 May; 34(2):147-53. PubMed ID: 21036399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Program Resources Required for Colonoscopy and Fecal Screening: Findings From 5 Years of the Colorectal Cancer Control Program.
    Subramanian S; Tangka FKL; Hoover S; Cole-Beebe M; Joseph D; DeGroff A
    Prev Chronic Dis; 2019 Apr; 16():E50. PubMed ID: 31022371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.
    Nadel MR; Royalty J; Shapiro JA; Joseph D; Seeff LC; Lane DS; Dwyer DM
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2834-41. PubMed ID: 23868477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.
    Seeff LC; DeGroff A; Joseph DA; Royalty J; Tangka FK; Nadel MR; Plescia M
    Cancer; 2013 Aug; 119 Suppl 15():2940-6. PubMed ID: 23868488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
    Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG; Habbema JD; Kuipers EJ
    J Natl Cancer Inst; 2009 Oct; 101(20):1412-22. PubMed ID: 19779203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
    Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
    Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruiting patients into the CDC's Colorectal Cancer Screening Demonstration Program: strategies and challenges across 5 sites.
    Boehm JE; Rohan EA; Preissle J; DeGroff A; Glover-Kudon R
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2914-25. PubMed ID: 23868486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 17. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals.
    Ladabaum U; Mannalithara A; Jandorf L; Itzkowitz SH
    Cancer; 2015 Apr; 121(7):1088-97. PubMed ID: 25492455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical case management and navigation for colonoscopy screening in an academic medical center.
    Cavanagh MF; Lane DS; Messina CR; Anderson JC
    Cancer; 2013 Aug; 119 Suppl 15():2894-904. PubMed ID: 23868484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.